361 Followers on Owler

ADC Therapeutics

is a Switzerland-based biotechnology company that develops proprietary antibody-drug conjugates for the treatment of solid and hematological cancers... Read more
OverviewCompetitorsFundingNews & Insights

ADC Therapeutics

is a Switzerland-based biotechnology company that develops proprietary antibody-drug conjugates for the treatment of solid and hematological cancers... Read more
ADC Therapeutics President & CEO: Ameet Mallik

President & CEO

Ameet Mallik

CEO Approval Rating

86/100

2011

PublicNYSEADCT

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$70.8M
Employees
265
Funding
$1.4B

News

Conference Presentation
Apr 01, 2025
PR Newswire
ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

ADC Therapeutics Competitors

1CytomX
2BioAtla
3ImmunoGen
4Astellas
5Genmab
6Pfizer
7Genentech
8Mersana
9MorphoSys
10Takeda Pharmaceutical
Unlock 13 + competitors

Trending Companies